UBS Lux Equity Fund Biotech USD vs Atlant Stability
1. UBS Lux Equity Fund Biotech USD
2. Atlant Stability
-
Security
Atlant Stability
-
Fee
0.50%
-
ISIN
SE0002623553
-
Holdings
20
Fund Holdings
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Atlant Stability, we have 1 holdings where is the largest holding (8.89), followed by (3.16) and (3.03).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Atlant Stability.
UBS Lux Equity Fund Biotech USD |
Atlant Stability |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. 8.89 % |
2. Moderna Inc 9.21 % |
2. 3.16 % |
3. Gilead Sciences Inc  4.66 % |
3. 3.03 % |
4. BioNTech SE 4.13 % |
4. 2.86 % |
5. Karuna Therapeutics Inc 3.75 % |
5. 2.42 % |
- |
6. 2.15 % |
- |
7. 2.08 % |
- |
8. 1.98 % |
- |
9. 1.87 % |
- |
10. 1.76 % |
- |
11. 1.65 % |
- |
12. 1.65 % |
- |
13. 1.54 % |
- |
14. 1.49 % |
- |
15. 1.47 % |
- |
16. 1.46 % |
- |
17. 1.44 % |
- |
18. 1.4 % |
- |
19. 1.35 % |
- |
20. 1.31 % |
The list of fund holdings was last updated on September 10, 2025.